The company's medical devices include a self-expanding heart pump and catheter-based therapy designed to manage congestion of heart failure patients through quicker and safer fluid and salt removal while protecting and potentiating kidney function. Magenta is also developing miniaturized catheter-mounted axial flow-pumps for mechanical circulatory support indications, including a percutaneous Left Ventricular Assist Device (pLVAD) for temporary support of patients undergoing high-risk coronary interventions and the treatment of patients admitted with cardiogenic shock.